However, there are few reports regarding the detection of ovarian clock-controlled genes (CCGs). The present study was designed to unravel the mechanisms through which CCG ovarian circadian oscillators regulate fertility, primarily using quantitative RT-PCR and RNA interference against Bmal1 in rat granulosa cells. Mature granulosa cells were prepared from mouse Per2-destabilized luciferase (dLuc) reporter gene transgenic rats. A real-time monitoring system of Per2 promoter activity was employed to detect Per2-dLuc oscillations. The cells exposed to luteinizing hormone (LH) displayed clear Per2-dLuc oscillations and a rhythmic expression of clock genes (Bmal1, Per1, Per2, and Dbp). Meanwhile, the examined ovarian genes (Star, Cyp19a1, Cyp11a1, Ptgs2, Lhcgr, and p53) showed rhythmic transcript profiles except for Hsd3b2, indicating that these rhythmic expression genes may be CCGs. Notably, Bmal1 small interfering (si)RNA treatment significantly decreased both the amplitude of Per2-dLuc oscillations and Bmal1 mRNA levels compared with nonsilencing RNA treatment in luteinizing granulosa cells. Depletion of Bmal1 by siRNA decreased the transcript levels of clock genes (Per1, Per2, Rev-erb␣, and Dbp) and examined ovarian genes (Star, Cyp19a1, Cyp11a1, Ptgs2, Hsd3b2, and Lhcgr). Accordingly, knockdown of Bmal1 also inhibited the synthesis of progesterone and prostaglandin E2, which are associated with crucial reproductive processes. Collectively, these data suggest that ovarian circadian oscillators regulate the synthesis of steroid hormones and prostaglandins through ovarian-specific CCGs in response to LH stimuli. The present study provides new insights into the physiologic significance of Bmal1 related to fertility in ovarian circadian oscillators.
predictable cyclic light signals, most organisms have evolved to exhibit diurnal dynamic behavioral and physiological rhythms, known simply as circadian rhythms. In mammals with an intact body system, circadian rhythms are ubiquitous, residing not only in the suprachiasmatic nucleus (SCN; also known as the central pacemaker of the circadian clock) but also in various peripheral tissues (regarded as peripheral circadian oscillators; Ref. 8) . The molecular machinery underlying circadian clocks in the SCN and peripheral tissues is composed of a conservative interlocked transcriptional-translational feedback loop involving multiple clock genes (Clock, Bmal1, Pers, and Crys) and their protein products that are required for generating endogenous circadian oscillations (22) . Furthermore, other accessory proteins including the orphan receptors (ROR and REV-ERBs) and DBP constitute additional loops that make circadian oscillators robust and tunable (16, 26, 35, 53) . In addition to regulating each other to sustain circadian oscillations, the core clock proteins (CLOCK, BMAL1, ROR, REV-ERBs, and DBP) also entrain rhythmic expression of numerous genes through binding to an E-box, ROR response element (RORE), and D-box at their promoters, which have been named clock-controlled genes (CCGs) with a large family. Existing evidence shows that the rhythmic expression of putative CCGs constitutes 8 -10% of expressed transcripts in some tissues (1, 50) .
In mammalian ovaries, folliculogenesis, follicular atresia, ovulation, luteinization, and luteolysis are obligatory processes that are regulated by endocrine, autocrine, and paracrine signals in a timely manner. Follicle-stimulating hormone (FSH) induces estradiol (E 2 ) production by induction of Cyp19a1 gene, whereas luteinizing hormone (LH) dramatically increases prostaglandin and progesterone (P 4 ) biosynthesis-related genes such as Ptgs2, Cyp11a1, Star, and Hsd3b2 (38, 47) . E 2 and FSH show the synergistic effects on granulosa cell proliferation and differentiation (LHCGR), whereas both P 4 and prostaglandin are essential for ovulation and luteinization (9 -11, 21, 28, 39, 41) . However, how LH acts on granulosa cells via specific mechanisms has not been fully explored.
In the last decade, there has been a growing number of investigations focusing on ovarian circadian oscillators (3, 5-7, 13, 19, 31, 32, 45) . Dexamethasone was proven to entrain the ovarian circadian oscillators and the rhythmic expression of core clock genes such as Bmal1, Per2, and Rev-erb␣ in rat mature granulosa cells (6, 7) . Similarly, 50% horse serum treatment for 2 h also induces the rhythmic expression of core clock genes and Per2-destablized luciferase (dLuc) (unpublished data from our laboratory). These results indicate that ovarian granulosa cells share a similar molecular clock mechanism as that of the SCN. Likewise, LH surges have been investigated to determine whether their presence acts as physiological stimulus of ovarian circadian oscillators. Our previous study proved that LH treatment entrains Per2-dLuc oscillations in rat mature granulosa cells (19) . In addition, other studies provided further evidence that LH regulates and orchestrates ovarian circadian oscillators in rodents and birds (51, 54) . Thus LH has been demonstrated to be a potent endocrine stimulus that synchronizes ovarian circadian oscillators. However, in spite of an increasing number of reports on ovarian ciradian oscillators, most focus on the existence of the ovarian circadian clock and its upstream stimulating factors. It remains elusive how the ovarian circadian oscillator coordinates and regulates ovarian reproductive physiology in response to LH.
BMAL1, an important core clock protein, is indispensable in maintaining the integrity of the circadian feedback loop and the homeostasis of numerous behaviors and physiological processes (4, 15, 23-25, 40, 44, 55) . Recent genetic studies also strongly suggest an important role of Bmal1 in mammalian reproductive physiology. Bmal1 Ϫ/Ϫ mice are infertile with profound reproductive defects, such as altered serum gonadotrophins concentrations, impaired steroidogenesis, and disrupted estrous cyclicity (2, 3, 37) . Star was proven as a CCG under the direct regulation of ovarian circadian oscillators, whose impaired expression in Bmal1 Ϫ/Ϫ mice results in low P 4 levels (3, 37). Although it is well documented that Bmal1 plays an important role in ovarian physiology, there is much more work to be done on unraveling the implicated mechanisms. Therefore, the detection of ovarian CCGs may aid us to unravel the elusive issues. RNA interference against Bmal1 in mature granulosa cells may provide a simple and useful tool for unraveling the ovarian CCGs under the control of ovarian circadian oscillators.
In consideration of the aforementioned evidence, we hypothesized that ovarian circadian oscillators directly drive the expression of numerous ovarian CCGs as well as the secretion of important hormones in response to LH surges. Seven ovarian granulosa cells expressed genes with the presence of circadian clock controlled cis-regulatory elements (E-box, RORE, and D-box) in their promoters were selected for analysis, whose proteins are involved with steroid hormone synthesis, granulosa cell differentiation, and cell cycle. We therefore examined mature granulosa cells prepared from Per2-dLuc transgenic rats with Bmal1 small interfering (si)RNA treatment to probe the ovarian CCGs. In this study, we determined whether LH treatment induces the rhythmic expression of choosing ovarian genes in rat mature granulosa cells, despite the presence of Per2-dLuc oscillations and the rhythmic expression of core clock genes. Additionally, we demonstrated that Bmal1 interference significantly inhibits the expression of core clock genes (Bmal1, Per1, Per2, Rev-erb␣, and Dbp) and a subset of choosing ovarian genes (Hsd3b2, Star, Ptgs2, Cyp11a1, Cyp19a1, and Lhcgr) in luteinizing granulosa cells, which results in impaired production of P 4 and prostaglandin E 2 (PGE 2 ). Hence, the present study provides new evidence that ovarian circadian oscillators regulate the synthesis of steroid hormones and PGE 2 through driving the expression of ovarian-specific CCGs in response to LH stimuli. In addition, the current results also suggest that Bmal1 plays a vital role in the regulation of core clock genes and a subset of CCGs related to fertility in ovarian circadian oscillators.
MATERIALS AND METHODS
Animals. Per2-dLuc transgenic rats were obtained from our breeding colony. In this transgenic rat line, the mouse Per2 promoter region, which is sufficient for circadian oscillation, was fused to a dLuc reporter gene (18) Granulosa cell isolation and culture. Mature granulosa cells were isolated as described previously (17) . Briefly, immature female rats (21-23 days of age) were injected subcutaneously with 50 IU eCG (Aska Pharmaceutical), and their ovaries enriched in antral follicles were collected at ZT2 on day 4. Ovaries were incubated in DMEM/ F-12 (Invitrogen, Carlsbad, CA) containing 6 mM EGTA for 20 min and then in DMEM/F-12 containing 0.5 M sucrose for 15 min at 37°C.
Mature granulosa cells were harvested by puncturing the follicles with 27-gauge needles. The released cells were recovered by centrifugation and washed three times with DMEM/F-12. Cell viability was examined by the trypan blue exclusion method. Approximately 1 ϫ 10 6 granulosa cells were seeded on a 35-mm collagen-coated dish (Iwaki, Tokyo, Japan) with 2 ml DMEM/F-12 supplemented with 1ϫ antibiotic-antimycotic (AA; Nacalai Tesque, Kyoto, Japan), 1ϫ insulin-transferrin-selenium (ITS; Life Technologies, Grand Island, NY), 0.1% BSA (Sigma Chemicals), and 100 ng/ml FSH (NIH-oFSH-S16; supplied by Dr. A. F. Parlow, Harbor-Univeristy of California, Los Angeles, Medical Center, Torrance, CA). Cultures were carried out in a humidified atmosphere of 95% air-5% CO 2 at 37°C. Cells were cultured for 72 h before other treatments unless stated otherwise.
Real-time monitoring of Per2-dLuc oscillations. Attached mature granulosa cells cultured with FSH for 72 h were then exposed to serum-free medium supplemented with 15 mM HEPES, 0.1 mM luciferin (Wako, Tokyo), 0.1% BSA, 1ϫ AA, and 1ϫ ITS in the presence of 100 ng/ml ovine LH (NIDDK-oLH-26; supplied by Dr. A. F. Parlow) and then subjected to luminescence determination. Luciferase activity was chronologically monitored at 37°C with a Kronos Dio AB-2550 luminometer (ATTO, Tokyo, Japan) interfaced to a computer for continuous data acquisition, as described previously (5) . The data are presented as photon counts per minute. Bioluminescence data were detrended by subtracting the 24-h running average from the raw data. The amplitude and period of Per2-dLuc oscillations were documented from the second phase that appeared between 24 and 48 h after LH synchronization by the single Cosinor method using Timing Series Single 6.3 (Expert Soft Technology, Richelieu, France).
Bmal1 siRNA transfection. Three sequences targeting the Bmal1 mRNA and nonsilencing RNA for rat were purchased from BONAC (Kurume, Japan). The sequences of RNA oligos used are listed in Table 1 . The scrambled RNA for rat was used as nonsilencing RNA (BONAC, Kurume, Japan). Mature granulosa cells were first plated in 35-mm collagen-coated dishes with 2 ml DMEM/F-12 supplemented with 1ϫ AA, 1ϫ ITS, 0.1% BSA, and 100 ng/ml FSH. After 24 h in culture, the medium was removed, and the Bmal1 siRNAs and nonsilencing RNA diluted in Opti-MEM were transfected into cells using Lipofectamine RNAiMAX reagent (Life Technologies, Grand Island, NY) according to the manufacturer's protocol. Both the Bmal1 siRNAs and nonsilencing RNA were used at final concentrations of 25 nM. The cells were maintained with transfection medium for duration of 12 h. Then, the medium was replaced with a medium supplemented with 1ϫ AA, 1ϫ ITS, 0.1% BSA, and 100 ng/ml FSH. After 48 h, some of the cells were synchronized in the presence of 100 ng/ml LH for detecting Per2-dLuc oscillations. The others were harvested for total RNA extraction at indicated time points after LH synchronization.
RNA extraction and quantitative RT-PCR. Cultured cells were harvested at indicated time points, and total RNA was isolated using an RNeasy Mini kit (Qiagen) according to the manufacturer's protocol. RNA samples were treated with RNase-free DNase (Qiagen). The cDNAs were generated by RT with oligo (dT) 15 and random primers using a GoTaq 2-Step RT-qPCR System (Promega, Madison, WI). The primer sets used for the quantitative (q)RT-PCR are listed in Table 2 . All primer pairs were designed to span introns to prevent amplification of product from genomic DNA. The qRT-PCR was performed in a 50-l volume containing a 20-ng cDNA sample in GoTaq qPCR Master Mix and 250 nM specific primers, with the Mx3000P Real-time qPCR System (Agilent Technologies, Santa Clara, CA) using the parameters as described in our previous report (6) . Melting peaks were determined with melting curve analysis to ensure the amplification and thus generation of single product. All reactions were performed in triplicate and displayed amplification efficiency between 80 and 120%. Relative quantification of each mRNA was performed using the comparative quantity (copies) method creating standard curves. Relative standard curves were created with serially diluted cDNA samples which were reverse transcribed from rat mature granulosa cells RNA samples. The cDNA samples were serially diluted by a factor of 3 (1, 3, 9, 27, 81, and 243 copies/l). This concentration range of standard curve sample was determined to be well within the detection level and sensitivity of the qPCR assay. The relative quantity for each sample was normalized to the average level of constitutively expressed housekeeping gene Gapdh (7). Gene expression was then normalized to the level of the gene of interest in the control samples.
Hormone assays. Culture supernatants were collected at 1 day after LH treatment. Then P 4 and PGE2 contents were measured using EIA kits (Cayman Chemical) according to the manufacturer's instructions. The intraassay and interassay variabilities were Ͻ10%.
Data analysis and statistics. Data are expressed as the means Ϯ SE of at least three separate experiments, each performed with triplicate samples. The circadian rhythmicity in gene expression was determined by the single Cosinor method using Timing Series Single 6.3 (Expert Soft Tech.). The Cosinor analyses were performed using a fixed period (24 h ) to test the hypothesis that rhythm amplitudes differed from zero (33) . For this, we fitted periodic sinusoidal func- tions to the relative values for the expression of each of the genes across seven time points (24 h) using the formula f (t) ϭ M ϩ A cos (2t/24 ϩ ), where f (t) is the level of gene expression across time, the mesor M is the value about which the level of expression oscillates, A is the amplitude of oscillation in expression, t is time in hours, and is the acrophase (time of peak expression). Rhythmicity was defined by a confidence region for the mesor using a t-distribution with the level of significance taken as Յ5% (33) . Other statistical analyses were performed by two-way ANOVA or Student's t-test, as indicated using SigmaPlot software (Ver. 12.0; Systat Software, San Jose, CA). Differences were considered significant at P Ͻ 0.05 or less.
RESULTS
LH synchronized circadian clockwork in rat mature granulosa cells. To determine whether LH can orchestrate the diurnal rhythmic expression of canonical clock genes, cultured mature granulosa cells were treated with 100 ng/ml LH. The Per2-dLuc bioluminescence expression profiles were firstly monitored using mature granulosa cells after LH treatment. These cells exhibited robust Per2-dLuc oscillations with the presence of 100 ng/ml LH (Fig. 1A) . To further investigate the circadian clockwork in luteinizing granulosa cells, we used a qRT-PCR approach to examine the canonical clock gene expression profiles using RNA samples collected at the indicated time points according to the first Per2-dLuc oscillation between 10 and 34 h. The results are presented in Fig. 1B .
The presence of LH entrained the majority of the examined clock genes (Bmal1, Per2, Rev-erb␣, and Dbp) with robust rhythmic expression (P Ͻ 0.001) in mature granulosa cells. Per1 mRNA levels across 24 h showed a less changing but rhythmic expression (P Ͻ 0.05). In contrast, Clock transcripts showed at a constant diurnal level that did not follow any significant circadian pattern. Rev-erb␣ and Dbp expression showed similar circadian patterns that peaked ϳ28 h and reached bottom at 16 h after LH treatment. Per2 and Bmal1 expression displayed a circadian pattern with opposing phases in mature granulosa cells. The Rev-erb␣ and Dbp transcripts rhythms were also out-of-phase with the Bmal1 rhythm.
Ovarian gene expression profiles across 24 h in luteinizing granulosa cells. To achieve further insight into the ovarian cellular clock and circadian regulation of physiology, seven genes that are vital for normal ovarian function were chosen and subjected to qRT-PCR to detect their expression profiles across 24 h. The large majority of examined genes (Star, Cyp19a1, Cyp11a1, Ptgs2, Lhcgr, and p53) displayed rhythmic transcript patterns except for Hsd3b2, as shown in Fig. 2 . There was not a rhythmic expression of Hsd3b2 mRNA level in spite of the presence of a large variation across 24 h. Cyp11a1 and p53 showed a parallel rhythmic pattern with a peak of expression at ϳ26 h after LH treatment. Star and Ptgs2 also exhibited a mimicking expression profile with a 2-h delay of peak expression. In contrast, the expression levels of Cyp19a1 and Lhcgr showed an anti-phase rhythmic profile that peaked at about 16 and 20 h, respectively, followed by a subsequent sharp downward tendency after LH treatment. Mature granulosa cells cultured with follicle-stimulating hormone (FSH) for 3 days were then subjected to 100 ng/ml LH for bioluminescence determination (time: 0 h). B: according to the first Per2-dLuc phase, total RNA samples were collected at the indicated times (black bar). Quantitative (q)RT-PCR analyses of transcript levels were performed using their specific primers. Gapdh was used as an internal control. Each value represents the means Ϯ SE of 3 separate experiments. The Cosinor analysis method was used to determine the rhythmic expression of examined genes; the dot lines show the fitting curves. P Ͻ 0.05 was considered a rhythmic expression.
Effects of Bmal1 siRNA treatment on Per2-dLuc oscillations in luteinizing granulosa cells. Given the important role of Bmal1 in sustaining cellular circadian rhythm, Per2-dLuc oscillations were investigated using mature granulosa cells with the presence of Bmal1 siRNA (siRNA) or nonsilencing RNA (CONT). Luteinizing granulosa cells with either treatment demonstrated several Per2-dLuc oscillations (Fig. 3A) . A decline of Per2-dLuc bioluminescence expression and significantly decreased oscillation am- plitude (P Ͻ 0.001, vs. CONT) in Bmal1 siRNA-treated cells were observed (Fig. 3) . There was not a significant effect of Bmal1 siRNA treatment on the period (Fig. 3B) .
Effect of Bmal1 knockdown on the expression of ovarian genes of luteinizing granulosa cells.
To gain a greater understanding of the physiological function of the ovarian circadian clockwork and to detect the specific CCGs under the regulation of ovarian circadian oscillators, we evaluated the expression of a subset of genes including canonical core clock genes and ovarian genes in luteinizing granulosa cells with or without Bmal1 siRNA treatment. The results are shown in Fig. 4 . Bmal1 mRNA expression levels across 24 h were significantly inhibited after transfection with Bmal1 siRNA (two-way ANOVA, P Ͻ 0.001). Per1, Per2, Rev-erb␣, and Dbp are regarded as core clock genes that fall under the regulation of BMAL1-CLOCK heterodimer through E-box elements located in their promoter regions. Thus Per1, Per2, Rev-erb␣, and Dbp transcripts profiles were significantly downregulated in Bmal1 siRNA cells (two-way ANOVA, P Ͻ 0.001), in spite of a less variation of Per2 mRNA levels. Interestingly, we observed that the monolithic mRNA expression levels of several ovarian genes (Star, Cyp11a1, Cyp19a1, Hsd3b2, Ptgs2, and Lhcgr) across 24 h were significantly inhibited in the Bmal1 siRNA treatment group, compared with that in the CONT group (two-way ANOVA, P Ͻ 0.001). The mRNA expression profile of the p53 was not affected by Bmal1 silencing (two-way ANOVA, P Ͼ 0.05).
Effect of Bmal1 knockdown on P 4 and PGE 2 production in mature granulosa cells. Steroidogenic acute regulatory protein (StAR) and prostaglandin-endoperoxide synthase 2 (PTGS2, or cyclooxygenase 2) are the key proteins for producing P 4 and PGE 2 , respectively. Therefore, we tested whether Bmal1 knockdown decreased the production of P 4 and PGE 2 to confirm the altered genes expression. Consistent with downregulation of Star and Ptgs2 by Bmal1 siRNA, Bmal1 interference was also found to significantly decrease the secretion of P 4 and PGE 2 compared with the CONT group (Fig. 5) .
DISCUSSION
During the past decade, increasing evidence has come to light that peripheral circadian oscillators orchestrate and coordinate integral and unique physiological processes like gluco- Mature granulosa cells were treated with Bmal1 siRNA (siRNA, black line) or nonsilencing RNA (CONT, grey line) according to the indicated protocols. Cells were then subjected to 100 ng/ml LH treatment. Total RNA samples were collected at the indicated times across 24 h after LH treatment. qRT-PCR analyses of transcript levels were performed using their specific primers. The relative mRNA expression was normalized to Gapdh and expressed as relative to the first time point (10 h) of CONT group. Each value represents the means Ϯ SE of 3 independent determinations. Two-way ANOVA were performed to investigate the main effects of Bmal1 siRNA treatment on examined genes expression. Differences were considered significant at P Ͻ 0.05 or less.
corticoid production (48) and parturition (36) . However, the specific physiological functions that are regulated by ovarian circadian oscillators remain to be determined. In the present study, we have attempted to unravel the implicated physiological roles of ovarian circadian oscillators in response to LH treatment through probing specific ovarian CCGs using RNA interference against Bmal1 in mature granulosa cells. Our data indicate that ovarian circadian oscillators in response to LH entrainment may regulate the production of important hormones (steroid hormones and PGE 2 ) through driving the expression of a subset of ovarian CCGs. Additionally, our results suggest that Bmal1 plays an important role in ovarian physiology.
Substantial evidence showed that both FSH and LH are potent endocrine signals that regulate and drive the ovarian circadian oscillators in rodents and birds (19, 20, 51, 54) . Moreover, two recent reports from our laboratory further extended previous evidence that FSH induces the maturation of circadian clock system in rat granulosa cells, showing that immature granulosa cells lack the expression of rhythmical clock genes, whereas mature granulosa cells pretreatment with FSH for 2 or 3 days gain a functional cellular clock rhythm (6, 7) . We therefore proposed that FSH provides an endocrine cue for the maturation of ovarian circadian clock system; thereafter, LH synchronizes the ovarian circadian oscillators. Based on the existing evidence, our current study adopted mature granulosa cells prepared from Per2-dLuc transgenic rats that were cultured with FSH for 3 days before LH treatment, intending to make granulosa cells gain a functional clock rhythm. Consistently, our results supply further evidence that LH treatment induces the presence of Per2-dLuc oscillations and the rhythmic expression of canonical clock gene mRNAs in mature granulosa cells (Fig. 1) . These results suggest that LH may acts on ovarian physiology through ovarian circadian clockworks. However, the existing information about how ovarian circadian oscillators act as a mediator between LH and ovarian physiology is limited. Therefore, further studies are required to elucidate the specific mechanisms.
Despite the clear evidence for all canonical clock genes being expressed in mammalian ovaries or ovarian cells, their impact on ovarian function remains obscure (6, 7, 13, 19, 31) . Ovarian CCGs may be an effective way to clarify the physiological function of ovarian circadian oscillators. Indeed, recent reports have carried on the positive exploration on this issue and identified that Star expression and P 4 production are under the regulation of ovarian circadian oscillators (3, 5, 6, 45) . To further screen more ovarian clock-related genes implicated with ovarian circadian oscillators, we chose a subset of ovarian genes (Table 3) containing clock controlled cis-regulatory elements (E-box, RORE, and D-box) within their promoters and examined their expression profiles across 24 h corresponding to the first Per2-dLuc oscillation in mature granulosa cells. Interestingly, the majority of the examined genes (Star, Cyp19a1, Cyp11a1, Ptgs2, Lhcgr, and p53) displayed rhythmic expression of mRNA levels according to analysis by the Cosinor method (Fig. 2) (33) , indicating that ovarian circadian oscillators may regulate diverse physiological processes through these genes, such as hormonal secretion (E 2 , P 4 , and PGE 2 ), granulosa cell differentiation, and cell cycle. These present findings are partially in agreement with previous evidence showing that Star and Ptgs2 are canonical or putative CCGs under the regulation of diverse peripheral circadian oscillators (3, 27, 30, 32) . However, the rhythmic expression of the examined ovarian genes does not constitute strong proof that these genes are CCGs. Therefore, Bmal1 interference in mature granulosa cells, which impairs the ovarian circadian oscillators, provides an ideal method of confirming which genes are CCGs.
It is well established that Bmal1 is indispensable in sustaining the transcriptional-translational feedback loop. Consistently, a previous study revealed impaired low mRNA expression of Per1, Per2, and Dbp in Bmal1 Ϫ/Ϫ mice (4). Another report showed that Rev-erb␣ and Dbp mRNAs reach baseline levels across 24 h at diestrus in the ovaries of Bma1 null mice (3). Consistent with prior reports, the present results revealed that Bmal1 interference significantly diminishes the amplitude of Per2-dLuc oscillations, as well as the mRNA levels of core The cells were then subjected to 100 ng/ml LH for 1 day. Culture supernatants were collected immediately for hormones determination after the completion of the above incubation times. Each value represents the means Ϯ SE of 3 independent determinations. Differences were considered significant at P Ͻ 0.05 or less. clock genes (Per1, Per2, Rev-erb␣, and Dbp; Figs. 3 and 4) , indicating that ovarian circadian oscillators have been impaired in Bmal1 siRNA-treated granulosa cells, which provide a prerequisite for further detection of ovarian CCGs.
In the present study, it is noteworthy that the downregulation of Bmal1 significantly inhibited Star, Cyp11a1, Cyp19a1, Ptgs2, Hsd3b2, and Lhcgr mRNA expression, except p53 (Fig.  4) . Because of the presence of clock controlled cis-regulatory elements within their promoters and their rhythmical expression, the present results suggest that these genes are perhaps directly under the regulation of ovarian core clock genes, such as Bmal1, Clock, Dbp, Rev-erb␣, and Ror␣. However, we cannot deny the possibility that some of them are under the regulation of CCGs, not core clock genes.
p53 is a tumor suppressor protein that has various physiological functions, such as G1 cell cycle arrest, apoptosis, and senescence (52) . A report demonstrated that Bmal1 siRNA treatment inhibited the mRNA expression of p53 in mouse colon carcinoma C26 cells and mouse fibroblast L929 cells (55) . In the current study, however, Bmal1 siRNA treatment did not have an impact in altering p53 mRNA expression, which is not consistent with its rhythmic expression in rat mature granulosa cells (Figs. 2 and 4) . One possible explanation is that p53 is a tissue or species-specific CCG, which is not driven by rat ovarian circadian oscillators. In addition, Lhcgr and Cyp19a1 are two crucial genes that are implicated with granulosa cell differentiation and E 2 biosynthesis, respectively. It was reported that Clock siRNA treatment in bovine granulosa cells significantly inhibits E 2 production and the expression of Lhcgr and Cyp19a1 (45) . Consistent with the existing evidence, our current results showed that the expression of Lhcgr and Cyp19a1 was significantly repressed by Bmal1 interference (Fig. 4) .
Additional selected genes (Star, Cyp11a1, and Hsd3b2) are also crucial for steroid hormone synthesis (29) . StAR is an indispensable protein that facilitates the entry of cholesterol into the inner mitochondrial membrane in steroidogenic cells as a rate-limiting step (49) . Cytochrome P450 side-chain cleavage enzyme (Cyp11a1) then converts cholesterol to pregnenolone, and thereafter, 3␤-hydroxysteroid dehydrogenase (Hsd3b2) converts pregnenolone to P 4 (29) . It was reported that the expression profile of Hsd3b2 changed over 24 h especially in the largest preovulatory follicles in laying quail (32) . Hsd3b2 mRNA expression was also found to be significantly attenuated in the testis of Bmal1 knockout mice (2) . Notably, increasing evidence has strongly implied that Star is a canonical CCG under the regulation of clock oscillators (2, 3, 14, 32, 37, 48) . Both male and female Bmal1 null mice exhibited impaired Star mRNA levels and sex steroid hormones (P 4 , testosterone) serum concentrations (2, 3) . In the present study, our results revealed that the downregulation of Bmal1 significantly attenuates Star, Cyp11a1, and Hsd3b2 mRNA levels and P 4 secretion, which further confirm them as CCGs (Figs. 4 and 5). P 4 is indispensible in the maintenance of successful embryo implantation. Therefore, our results suggest that impaired ovarian circadian oscillators secrete low P 4 , which leads to implantation failure. Consistent with our hypothesis, a recent study showed that Baml1 Ϫ/Ϫ mice did not exhibit successful embryo implantation, whereas exogenous P 4 treatment is able to restore implantation (37) .
PTGS2 is an important rate-limiting enzyme determining the production of PGE 2 , which is required for successful ovulation as demonstrated by existing evidence (11, 12, 34, 46) . Previous reports have shown that the Ptgs2 gene contains E-box within its promoters, which is required for promoter activity in rat and bovine granulosa cells, indicating that Ptgs2 is a CCG under the regulation of ovarian circadian oscillators (27, 30) . Recently, Sellix and colleagues (42, 43) proposed the similar idea that Ptgs2 is a CCG governed by ovarian circadian oscillators, whose rhythmic expression might contribute to the timing of ovulation. Here, we provided the first evidence that Bmal1 interference in rat mature granulosa cells significantly decreased Ptgs2 mRNA level and PGE 2 production, in agreement with previous evidence and hypothesis (Figs. 4 and 5) (27, 30, 42, 43) . Consistently, a prior work illustrated that the ovaries of Bmal1null mice at 2 mo of age frequently exhibited impaired structures with presumably large antral follicles which failed to ovulate (3). Conceivably, Ptgs2 may be regarded as a CCG that is involved with normal ovulation in mammals (Fig. 6) .
Unlike our results, however, Boden et al. (3) showed that the ovaries of Bmal1 null mice did not display low mRNA expression of Per2, Hsd3b2, Lhcgr, and Cyp11a1, but high expression levels compared with the wild-type mice. This discrepancy might be in part due to the reason that ovarian CCGs display a species-specific feature. It is also possible that increased expression of Per2, Hsd3b2, Lhcgr, and Cyp11a1 in the ovaries of Bmal1 null mice results from impaired central clocks, accompanying impaired endocrine signals. A recent report showed that male Bmal1 knockout mice had high LH and low FSH serum levels (2) .
In the present study, we adopted a unique granulosa cell culture model to detect the CCGs of ovarian circadian oscillators, which contains some intrinsic advantages compared with organ and in vivo studies. First, the culture of granulosa cells in serum-free medium eliminates many serum-contained factors that have influences on ovarian circadian oscillators to highlight gonadotropin (FSH and LH) actions. Second, the cell culture method (plus FSH treatment for 3 days before LH synchronization) guarantees that mature granulosa cells acquire functional circadian clocks to a large extent. However, in organ or in vivo studies, granulosa cells from ovaries remain in different differentiation states, which are not suitable for unravel CCGs, because prior evidence demonstrated that the circadian clockwork of ovarian cells is affected during cellular differentiation (6, 7, 18) . Third, as we discussed above, Bmal1 interference in granulosa cell cultures provides a direct and simple tool to detect ovarian CCGs, without thinking about the influence of other altered endocrine signals on ovarian gene expression. However, in spite of many advantages, our current study has some limitations. One limitation is that our study did not unravel the specific molecular mechanism through which circadian clock-controlled cis-regulatory elements these ovarian CCGs are under the regulation of ovarian circadian clockworks. Another limitation is that our results mainly rely on in vitro studies; there is a deficiency of in vivo studies. Further exploration of the physiological roles of ovarian circadian oscillators in vivo is warranted. For example, the generation of ovary-specific Bmal1 knockout mice, which avoids the presence of impaired circadian oscillators in whole body Bmal1 null mice, may aid us to further identify the CCGs and implicated physiological functions under the regulation of ovarian circadian oscillators.
In conclusion, our results demonstrate that ovarian circadian oscillators regulate a subset of ovarian-specific CCGs expression and some hormone secretion (P 4 and PGE 2 ) in response to LH stimuli (Fig. 6) , which provides new evidence on the physiologic significance of ovarian circadian oscillators and LH action on ovarian circadian oscillators. Our findings also suggest that an ovarian core clock gene, Bmal1, is required for the sustainment of normal ovarian physiology, which is associated with reproductive processes such as ovulation and embryo implantation. This work may contribute to our understanding on the mechanism how circadian disruption affects the mammals' fertility. 
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